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Many cellular responses, such as autoimmunity and
cytotoxicity, are controlled by receptors with cyto-
plasmic immunoreceptor tyrosine-based inhibition
motifs (ITIMs). Here, we showed that binding of inhib-
itory natural killer (NK) cell receptors to human leuko-
cyte antigen (HLA) class I on target cells induced
tyrosine phosphorylation of the adaptor Crk, con-
comitant with dephosphorylation of the guanine ex-
change factor Vav1. Furthermore, Crk dissociated
from the guanine exchange factor C3G and bound
to the tyrosine kinase c-Abl during inhibition. Mem-
brane targeting of a tyrosine-mutated form of Crk
could overcome inhibition of NK cell cytotoxicity,
providing functional evidence that Crk phosphoryla-
tion contributes to inhibition. The specific phosphor-
ylation of Crk and its dissociation from a signaling
complex, observed here with two types of inhibitory
receptors, expands the signaling potential of the
large ITIM-receptor family and reveals an unsus-
pected component of the inhibitory mechanism.
INTRODUCTION
Maintenance of a proper balance in cellular activation often re-
quires control by inhibitory receptors. Many receptors provide
negative regulation by recruiting the tyrosine phosphatases
SHP-1 and SHP-2 to phosphorylated immunoreceptor tyro-
sine-based inhibition motifs (ITIMs) in the receptor cytoplasmic
tail (Burshtyn et al., 1996; Long, 2008; Olcese et al., 1996). A
few examples of the diverse functions under negative regulation
by ITIM-containing receptors include T cell-mediated autoimmu-
nity, controlled by programmed death-1 (PD-1) (Okazaki and
Honjo, 2006); limitation of plasticity in the visual cortex by paired
immunoglobin (Ig)-like receptor B (PIRB) (Syken et al., 2006); and
red cell engulfment by macrophages, which is inhibited through
binding of signal-regulatory protein a (SIRPa) to CD47 (Olden-
borg et al., 2000). Natural killer (NK) cell activation and cytotox-
icity are inhibited by human killer cell Ig-like receptors (KIR)
and mouse Ly49 receptors, as well as the conserved CD94-
NKG2A receptor, all of which bind to major histocompatibility
complex (MHC) class I molecules on target cells (Lanier, 1998).
Given the importance of ITIM-containing receptors in control-
ling cellular responses, it is of obvious interest to elucidate the
inhibitory signaling pathway. In the case of NK cell contact578 Immunity 29, 578–588, October 17, 2008 ª2008 Elsevier Inc.with target cells, cytotoxicity is induced by multiple activation
pathways, which operate both in parallel and in synergy (Bryce-
son et al., 2005; Bryceson et al., 2006). This raises the question of
how activation of NK cells through different signaling pathways
can be blocked by a single inhibitory mechanism. The identifica-
tion of Vav1 as a specific substrate of SHP-1 during inhibition of
NK cells by engagement of HLA class I on target cells suggested
that KIR blocks activation at a central common point in NK cell
activation, rather than by dephosphorylation of several effector
molecules involved in signaling by different receptors (Stebbins
et al., 2003). Vav1 is a multifunctional protein, acting as an adap-
tor through SH2 and SH3 domains and as a guanine exchange
factor (GEF) for the small GTPases Rac1 and Cdc42. A central
role of Vav1 in T cell development and in formation of functional
immune synapses is well established (Tybulewicz, 2005).
Besides their role in blocking NK cell cytotoxicity toward
healthy cells, MHC class I-specific NK cell inhibitory receptors
have been assigned another function. They adjust the respon-
siveness of each NK cell according to the strength of inhibitory
signals received. For example, NK cells that express several in-
hibitory receptors are intrinsically more responsive, whereas NK
cells devoid of inhibitory receptors for self MHC are hyporespon-
sive (Anfossi et al., 2006; Fernandez et al., 2005; Kim et al., 2005).
Several models have been proposed to account for this property
of ITIM-containing NK cell receptors, including a ‘‘licensing’’
model, which could involve an instructive signal (Yokoyama
and Kim, 2006), and a ‘‘disarming’’ model, whereby lack of inhib-
itory signals results in unresponsiveness, akin to anergy (Gasser
and Raulet, 2006). Although licensing ofmouseNK cells by inhib-
itory Ly49 is ITIM dependent (Kim et al., 2005), the nature of the
signal and the point at which it regulates NK cell activity are still
unknown.
To better understand how inhibition is achieved, we examined
changes in phosphorylatedmolecules associated with Vav1 dur-
ing inhibition of NK cells by KIR.We sought to identify changes in
early activation signals by using NK cells that were stimulated by
direct contact with target cells. These target cells were either
sensitive to lysis (activating conditions) or resistant to lysis be-
cause of inhibitory receptor binding to specific HLA class I ligand
on the target. This experimental system, although technically
challenging, avoids the artificial use of antibodies to ligate NK
cell receptors and of solid supports to present ligands to NK
cell receptors. The results revealed an unexpected signal in-
duced by inhibition through KIR and CD94-NKG2A. During
inhibition, we observed the loss of association of tyrosine-phos-
phorylated Vav1 with c-Cbl, and we observed the tyrosine phos-
phorylation of the small adaptor molecule Crk. We provide
evidence that Crk phosphorylation induced specifically by
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tion of NK cells.
RESULTS
Vav1 Is a Target of Inhibition by KIR-SHP-1 in NK Cells
To explore the mechanism of inhibition by ITIM-containing NK
cell receptors, we first wanted to substantiate the evidence
that Vav1 is a selective substrate of SHP-1 during inhibition.
The identification of Vav1 as a substrate of SHP-1 during inhibi-
tion of NK cells by target cells expressing a ligand of KIR had re-
lied on the use of a ‘‘trapping’’ mutant of SHP-1 fused to
KIR2DL1 in place of the cytoplasmic ITIMs (Stebbins et al.,
2003). Because these results were obtained by expression of
KIR-SHP-1 chimeras in the NK cell line YTS, it remained to be
seen whether the selection of Vav1 as primary target for dephos-
phorylation during inhibition was representative of inhibition in
other NK cells. To test this, we transfected the chimeric
KIR2DL1-SHP-1 receptor, as well as the aspartic-acid-to-ala-
nine substrate-trapping mutant SHP-1(DA), into the human NK
cell line NK92 (Figure S1A available online). The IL-2-dependent
cell line NK92 has a phenotype and properties similar to those of
human IL-2-activated NK cells. Even a low expression of catalyt-
ically active KIR2DL1-SHP-1 was sufficient to inhibit lysis of 221
target cells expressing the HLA-Cw15 ligand of KIR2DL1, while
retaining lysis of cells expressing HLA-Cw3, an allele not recog-
nized by KIR2DL1 (Figure S1B). As expected, the catalytically in-
active KIR2DL1-SHP-1(DA) did not inhibit lysis of 221-Cw15
cells (Figure S1B).
The substrate-trapping experiment, conducted in the physio-
logical context of NK cell interaction with target cells (Stebbins
et al., 2003), was carried out in parallel with YTS and NK92 cells
expressing KIR2DL1-SHP-1(DA). Trapping of a tyrosine-phos-
phorylated protein in NK92-2DL1-SHP-1(DA), which comigrated
with Vav1 and with Vav1 trapped in YTS cells, was evident
(Figure S1C). Note that trapping of Vav1 by this approach implies
that Vav1 is dephosphorylated during inhibition and, hence, that
phosphorylated Vav1 should be absent during NK cell inhibition.
The tyrosine-phosphorylated protein of 125 kDa, detected af-
ter incubation with 221-Cw15 cells, is the chimeric KIR2DL1-
SHP-1(DA) receptor itself (Stebbins et al., 2003). Therefore, trap-
ping of a single dominant substrate, previously identified as Vav1
in YTS cells, occurred in both NK cell lines. We conclude that
Vav1 dephosphorylation by SHP-1 during KIR-mediated inhibi-
tion is a general feature of the inhibitory signaling pathway.
Phosphorylated Vav1 Associates with c-Cbl during NK
Cell Activation, but Not Inhibition
To investigate signaling events that occur during inhibition by an
ITIM-containing receptor, further experiments were carried out
with the unmanipulated (i.e., nonchimeric) inhibitory KIR2DL1 re-
ceptor expressed in YTS cells (Figure S2). YTS cells expressing
KIR2DL1 (YTS-2DL1 cells) kill 221-Cw3 cells, but not 221-Cw15
cells (Figure S2). After incubation of YTS-2DL1 cells with target
cells for 5 min at 37C, immunoprecipitates (IPs) of Vav1 were
probed with a phosphotyrosine antibody (Ab) to identify mole-
cules associated with Vav1 during activation or inhibition of
YTS-2DL1 cells (Figure 1A). Lysates of 221-Cw3, 221-Cw15,
and YTS-2DL1 cells prior to mixing were also tested. Strongtyrosine phosphorylation of Vav1 was observed, and it was high-
est after activating conditions. In addition, a tyrosine-phosphor-
ylated band at 120 kDa (indicated by an asterisk in Figure 1A)
was seen reproducibly in Vav1 IPs, specifically after stimulation
of YTS-2DL1 cells with 221-Cw3 cells, but not with 221-Cw15
Figure 1. Tyrosine-Phosphorylated Proteins Associated with Vav1
and c-Cbl during Activation and Inhibition of YTS-2DL1 Cells
YTS-2DL1 cells mixed with 221-Cw3 cells (2DL1+Cw3) and YTS-2DL1 cells
mixed with 221-Cw15 cells (2DL1+Cw15) were incubated for 5 min at 37C
and lysed. Lysates of each cell before and after mixing were immunoprecipi-
tated with Abs for Vav1 and c-Cbl, as indicated.
(A) Vav1 IPs were probed with anti-phosphotyrosine (p-Tyr) and reprobed with
anti-Vav1.
(B) c-Cbl IPs were probed with anti-phosphotyrosine and reprobed with anti-
c-Cbl.
(C) c-Cbl IPs were probed with anti-pY160-Vav1 and reprobed for c-Cbl. Data
are representative of at least five independent experiments.Immunity 29, 578–588, October 17, 2008 ª2008 Elsevier Inc. 579
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not seen in any of the cells prior to cell mixing (Figure 1A). Other
tyrosine-phosphorylated bands in the 50 and 70 kDa range have
not been seen reproducibly in several other experiments. Re-
probing with Abs for several proteins in the range of molecular
mass 120 kDa indicated that the tyrosine-phosphorylated
band comigrated with c-Cbl (data not shown). c-Cbl is known
to bind the Vav1 SH2 domain through its phosphorylated
YMTP motif at tyrosine 700 (Liu and Altman, 1998).
To test, conversely, whether phosphorylated Vav1 is associ-
ated with c-Cbl, we probed c-Cbl IPs for tyrosine-phosphory-
lated proteins by immunoblotting. Strong tyrosine phosphoryla-
tion of c-Cbl was observed, and it was highest after activating
conditions. In addition, a tyrosine-phosphorylated band at
95 kDa was seen specifically after stimulation of YTS-2DL1
cells with 221-Cw3 cells, but not with 221-Cw15 cells (indicated
by an asterisk in Figure 1B). Reprobing with a Vav1 Ab revealed
that the 95 kDa band comigrated with Vav1 (data not shown).
To confirm association of phospho-Vav1 with c-Cbl during
activation, we probed c-Cbl IPs with an Ab specific for phos-
phorylated tyrosine 160 in Vav1 (pY160-Vav1). An increase in
association of pY160-Vav1 with c-Cbl during activation was
clearly detected (Figure 1C).
Formation of phosphorylated c-Cbl-Vav1 complexes during
activation suggested that c-Cbl could be associated with Vav1
while Vav1 is dephosphorylated by SHP-1 during inhibition. In-
deed, a faint but distinct tyrosine-phosphorylated protein of
120 kDa, which comigrated with c-Cbl, has been seen repro-
ducibly after mixing YTS-2DL1-SHP-1(DA) cells with 221-Cw15
cells, but not after mixing with 221-Cw3 cells (Figure S3). This
phosphorylated protein of 120 kDa was not pulled down with
the null mutant 2DL1-SHP-1(RM), which does not bind phospho-
tyrosine (Figure S3). However, providing evidence of receptor
engagement, phosphorylation of receptor 2DL1-SHP-1(RM)
was clearly detected after mixing with 221-Cw15 cells, demon-
strating that the lack of a tyrosine-phosphorylated 120 kDa
protein was not due to defective ligand engagement by 2DL1-
SHP-1(RM) (Figure S3). These data suggest that phospho-Cbl
is either a direct substrate of SHP-1 or associated with Vav1
during dephosphorylation by SHP-1.
Association of CrkII with c-Cbl, p130CAS, and C3G
during Activation by Sensitive Target Cells
c-Cbl is a scaffold protein of the cytoskeleton; it promotes forma-
tion of a lamellipodium though its association with the SH2 do-
main of the small adaptor CrkII (Abassi and Vuori, 2002; Scaife
and Langdon, 2000). CrkII, as well as the related CrkL, consists
of an SH2 domain, which binds phosphorylated tyrosine 774 in
the YDVP motif of c-Cbl, and two SH3 domains. Through its
SH3 domain, CrkII recruits the GEF C3G, which activates the
GTPase Rap1 (Chodniewicz and Klemke, 2004). Several YxxP
motifs for binding of CrkII are also present in the scaffold protein
p130CAS. Given the potential role of CrkII-C3G and of CrkII as-
sociation with c-Cbl and p130CAS in activation of NK cell cyto-
toxicity, we examined such associations during activation and
inhibition of YTS-2DL1 cells mixed with target cells. Clear asso-
ciation of CrkII with c-Cbl, p130CAS, and C3G was induced by
activation, as detected by immunoblotting of CrkII in IPs
(Figure 2A). CrkII association with c-Cbl, p130CAS, and C3G580 Immunity 29, 578–588, October 17, 2008 ª2008 Elsevier Inc.was either reduced or absent after incubation with 221-Cw15
cells. The basal amount of p130CAS-CrkII complex in unstimu-
lated YTS-2DL1 cells was also dissociated during inhibition
(Figure 2A). Therefore, c-Cbl-CrkII, p130CAS-CrkII, and CrkII-
C3G signaling complexes are not present in YTS-2DL1 cells
that are inhibited by HLA-Cw15 on target cells.
CrkII Phosphorylation and Association with c-Abl
during KIR-Mediated Inhibition
Different mechanisms could account for the lack of c-Cbl-CrkII
and CrkII-C3G complexes during inhibition. First, these associa-
tions may never form because of inhibition of a step required up-
stream of this signaling complex. Another potential mechanism
is that inhibitory signals initiated by KIR2DL1 actively disassem-
ble complexes of CrkII with c-Cbl and C3G, for instance, by de-
phosphorylation of tyrosine 774 in c-Cbl. However, an alternative
and well-established mechanism for dissociation of CrkII from
c-Cbl is the phosphorylation of tyrosine 221 in CrkII by the tyro-
sine kinase c-Abl and the formation of a phospho-CrkII-Abl com-
plex (Chodniewicz and Klemke, 2004). This mechanism is not
dependent on dephosphorylation of pY774 in c-Cbl. CrkII phos-
phorylated at Y221 is autoinhibited by intramolecular binding of
its own SH2 domain. Furthermore, C3G is displaced by the
binding of the SH3 domain of c-Abl. We therefore examined
whether CrkII phosphorylation and association with c-Abl oc-
curred during inhibition of YTS-2DL1 cells.
Association of CrkII with c-Abl occurred during inhibition of
YTS-2DL1 cells mixed with 221-Cw15 cells, as detected by im-
munoblotting of CrkII in c-Abl IPs (Figure 2B). Furthermore, tyro-
sine phosphorylation of CrkII was detected during inhibitory
conditions, after mixing YTS-2DL1 cells with 221-Cw15 cells
(Figure 2B). Thus, these results show that a specific phosphory-
lation event occurs upon interaction of an inhibitory KIR with an
HLA class I ligand on target cells. It is likely that KIR-mediated
inhibitory signals induce CrkII phosphorylation for the purpose
of disassembling c-Cbl-CrkII-C3G and p130CAS-CrkII-C3G
complexes.
The biochemical experiments performed here with lysates of
NK cells mixedwith target cells do not discriminate between pro-
teins contributed by NK cells and those in target cells. It was
therefore possible that engagement of HLA-Cw15 could some-
how induce CrkII phosphorylation in 221 target cells. To address
this possibility, phosphorylation of CrkII was examined after mix-
ing YTS-2DL1 cells with 221 target cells that had been subjected
to light fixation in paraformaldehyde. The amount of total CrkII re-
leased by lysis of 221 cells was much reduced after fixation
(Figure 2C). Nevertheless, induction of CrkII tyrosine phosphory-
lation was clearly evident in lysates of YTS-2DL1 cells mixedwith
fixed 221-Cw15 cells (Figure 2D). The amount of phosphorylated
CrkII was in fact greater after mixing with fixed target cells. These
results support the conclusion that CrkII phosphorylation occurs
in NK cells during inhibition by KIR2DL1.
CrkII Association with c-Abl during KIR-Mediated
Inhibition of Primary NK Cells
An important question was whether dissociation of c-Cbl-CrkII
and CrkII-C3G complexes and association of CrkII with c-Abl
also occurred during inhibition of primary NK cells. Large num-
bers of primary NK cells were required to perform biochemical
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cause each individual NK cell expresses a small repertoire of
KIR and CD94-NKG2 receptors (Parham, 2005), it was neces-
sary to isolate NK cells that express a defined inhibitory KIR. An-
other complication is that mAbs to KIR2DL1 (CD158a) and to
KIR2DL2 and KIR2DL3 (CD158b) do not distinguish inhibitory
KIRs from the activating isoforms KIR2DS1 and KIR2DS2, re-
spectively. To identify inhibitory forms of KIR, we have generated
a rabbit polyclonal antiserum, called cyt42/43, specific for the
cytoplasmic tail of KIR2DL1 and KIR2DL2. Therefore, CD158a+
cyt42/43+ NK cells will be KIR2DL1+ and inhibited by HLA-Cw4
and HLA-Cw15 (Figure S4). By screening several individual do-
nors, we identified one that expressed KIR2DL1 in the absence
of KIR2DS1 on a high fraction of peripheral blood NK cells
(Figure S4).
A large number of primary NK cells that uniformly express
inhibitory KIR2DL1 were obtained by cell sorting (Figure S4).
Phosphorylation of Vav1 at tyrosine 160 was detected in the
IL-2-activated KIR2DL1+ NK cell population and increased after
stimulation with sensitive 221 target cells (Figure 3A). After mix-
ing with resistant 221-Cw15 cells, phosphorylation of Vav1 Y160
was even less than the basal amount in KIR2DL1+ cells
(Figure 3A). In addition, CrkII association with c-Cbl and with
C3G during activation, as well as association of CrkII with
c-Abl during incubation with resistant 221-Cw15 cells, were
clearly observed (Figure 3B). Some association of CrkII with
c-Abl also occurred during activation of NK cells, a result consis-
tent with the phosphorylation-dependent recruitment of CrkII
(Abassi and Vuori, 2002; Chodniewicz and Klemke, 2004). We
conclude that binding of inhibitory KIR2DL1 to an HLA class I
ligand on target cells induces active association of CrkII with
c-Abl in primary NK cells.
Inhibition by CD94-NKG2A Binding to HLA-E Induces
Crk Phosphorylation and Association with c-Abl
Binding of the lectin-like receptor CD94-NKG2A to HLA-E in-
hibits target cell lysis and prevents proper NK cell immune-syn-
apse formation (Masilamani et al., 2006). NKG2A and the Ig-like
inhibitory KIR are not structurally related and have opposite
transmembrane orientations, and yet they share ITIM sequences
in their cytoplasmic tails. It was therefore of interest to test
whether phospho-Vav1-c-Cbl, c-Cbl-Crk, and Crk-C3G associ-
ations were also inhibited through binding of CD94-NKG2A to
HLA-E on target cells. The CD94-NKG2A+ NK cell line NKL
Figure 2. CrkII Is Associated with c-Cbl, p130CAS, and C3G during
Activation but Phosphorylated during Inhibition
YTS-2DL1 cells were mixed with target cells as described in Figure 1.
(A) Lysates were immunoprecipitated with Abs to c-Cbl, p130CAS, and C3G,
as indicated, probed with anti-CrkII, and reprobed with Abs to the immunopre-
cipitated proteins.
(B) Lysates were immunoprecipitated with Abs to c-Abl, p-Tyr, and pY221-
CrkII. Membranes were immunoblotted with anti-CrkII and then reprobed
with Abs to the immunoprecipitated proteins.
(C) Whole-cell lysates of 221 cells, either fixed in 0.5% paraformaldehyde or
not, were immunoblotted with CrkII Ab.
(D) Cell mixing was performed in parallel with unfixed and fixed 221 cells. Ly-
sates were immunoprecipitated with 4G10 agarose and immunoblotted for
CrkII. Data are representative of at least three independent experiments.Immunity 29, 578–588, October 17, 2008 ª2008 Elsevier Inc. 581
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cells were killed by NKL, expression of HLA-E on transfected
221 cells (221-E cells) provided protection from lysis byNKL cells
(Figure S2).
After incubation of NKL cells with target cells for 5min at 37C,
strong tyrosine phosphorylation of c-Cbl was apparent, more so
with 221 cells than 221-E cells (Figure 4A). In addition, a phos-
phoprotein of 95 kDa appeared during activating conditions
only (indicated by an asterisk in Figure 4A). Association of phos-
pho-Vav1 with c-Cbl during activation, but not inhibition, was
demonstrated directly by probing the c-Cbl IP with the pY160
Vav1 Ab (Figure 4B). Therefore, association of phospho-Vav1
with c-Cbl is prevented or reversed during inhibition of NKL cells
by CD94-NKG2A.
Association of Crk with c-Cbl, p130CAS, and C3G was then
examined. The cell line NKL expresses mainly the lymphocyte-
specific member of the Crk family, CrkL (data not shown).
Formation of c-Cbl-CrkL and p130CAS-CrkL complexes was
detected after incubation with 221 cells, but not 221-E cells
(Figure 5A). Furthermore, association of CrkL with C3G was
reduced when NKL cells were incubated with resistant 221-E
target cells (Figure 5A). If CrkL forms ternary complexes by si-
multaneous binding to c-Cbl and C3G through its SH2 and
Figure 3. Formation of CrkII-c-Abl Complexes during Inhibition of
Primary NK Cells
KIR2DL1+ NK cells were mixed with 221 cells and 221-Cw15 cells for 5 min at
37C. Cells lysates were immunoprecipitated with Abs to (A) Vav1 and (B)
c-Cbl, C3G, and c-Abl. Blots were probed with Abs to (A) pY160-Vav1 and
(B) CrkII and then reprobed for the indicated proteins. Data are representative
of at least four independent experiments.582 Immunity 29, 578–588, October 17, 2008 ª2008 Elsevier Inc.SH3 domains, respectively, it may be possible to detect C3G
in c-Cbl IPs. Indeed, C3G was detected in IPs of c-Cbl from
lysates of NKL cells that had been incubated with 221 cells,
but not 221-E cells (Figure 5B). These results are consistent
with formation of a trimolecular complex c-Cbl-CrkL-C3G.
Association of CrkL with c-Abl and tyrosine phosphorylation of
CrkL were clearly detected after inhibition of NKL cells by 221-E
cells (Figure 5C). The small amount of c-Abl-CrkL complex and of
phosphorylated CrkL observed after activation by 221 cells is
consistent with the phosphorylation-dependent membrane re-
cruitment of Crk (Abassi and Vuori, 2002; Chodniewicz and
Klemke, 2004). In conclusion, engagement of CD94-NKG2A by
HLA-E has the same outcome as the inhibitory KIR2DL1-HLA-
Cw15 interaction, in that they both prevent formation of Crk
complexes with scaffold proteins c-Cbl and p130CAS and re-
cruitment of C3G by Crk. Furthermore, they both induce specific
tyrosine phosphorylation of the adapters CrkII and CrkL and their
Figure 4. Tyrosine-Phosphorylated Proteins Associated with c-Cbl
during Activation and Inhibition of NKL Cells
NKL cells were mixed with 221 or 221-E cells, incubated for 5 min at 37C, and
lysed. Lysates were immunoprecipitated with anti-c-Cbl.
(A) IPs were immunoblotted with anti-phosphotyrosine and reprobed with anti-
c-Cbl. A long and a short exposure of the phosphotyrosine immunoblot are
shown, as indicated.
(B) IPs were probed with anti-pY160-Vav1 and reprobed for c-Cbl. Data are
representative of at least three independent experiments.
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specific Crk tyrosine phosphorylation is a general feature of neg-
ative signaling by ITIM-containing receptors rather than a pecu-
liar feature of inhibitory KIR.
Membrane Targeting of a Tyrosine Mutant of CrkII
Overcomes Inhibition
If Crk phosphorylation and Crk dissociation from signaling com-
plexes were to participate in the inhibitory mechanism of ITIM-
Figure 5. CrkL Phosphorylation and Association with c-Abl during
Inhibition by CD94-NKG2A
NKL cells were mixed with 221 or 221-E cells, incubated at 37C for 5 min, and
lysed.
(A) Lysates were immunoprecipitated with Abs to c-Cbl, p130CAS, and C3G.
Membranes were immunoblotted with anti-CrkL and then reprobed with Abs
to the immunoprecipitated proteins.
(B) Lysates were immunoprecipitated with anti-c-Cbl, and membranes were
immunoblotted for C3G and reprobed for total c-Cbl.
(C) Lysates were immunoprecipitated with Abs to c-Abl and phosphotyrosine,
and membranes were immunoblotted with anti-CrkL and then reprobed with
Abs to c-Abl. Data are representative of at least three independent experi-
ments.containing receptors, it would follow that Crk has a positive
role during activation of NK cells. To test this, we performed CrkII
siRNA knockdown experiments with YTS-2DL1 cells. Out of six
independent experiments, in which partial knockdown of CrkII
was achieved, the cytotoxic activity of YTS-2DL1 cells toward
221 cells was reduced by 14%± 5.6% (Figure S5). Loss-of-func-
tion experiments suffer from the possibility of indirect effects or
nonspecific inhibition. Experiments in which function is restored
providemore direct evidence for the role of a specific protein.We
therefore investigated the possibility of restoring cytotoxic func-
tion in NK cells during inhibitory signaling by an ITIM-containing
receptor.
The most important question here was whether phosphoryla-
tion of Crk and formation of Crk-Abl complexes contributes to
inhibition of NK cell cytotoxicity. Simple experiments using the
c-Abl inhibitor Gleevec (STI571) to prevent Crk phosphorylation
by c-Abl were not an option because c-Abl inhibition compro-
mised NK cell cytotoxicity toward sensitive target cells (data
not shown). This was not a surprising result, given that c-Abl par-
ticipates in signaling pathways, for example, by phosphorylation
of ZAP70 downstream of the TCR (Zipfel et al., 2004), and partic-
ipates in actin cytoskeleton remodeling through direct binding to
F-actin (Woodring et al., 2003) and phosphorylation of WAVE2
(Stuart et al., 2006).
A tyrosine-mutated form of CrkII, which cannot be phosphory-
lated by c-Abl, has the potential to remain bound to phospho-
Y774 in c-Cbl and to interfere with inhibition by KIR2DL1.
However, such an approach was not feasible either because
membrane recruitment of CrkII requires phosphorylation at
Y221 (Abassi and Vuori, 2002). Instead, our chosen approach
was to express in YTS-2DL1 cells a membrane-targeted mutant
of CrkII, in which tyrosine 221 was mutated to a phenylalanine
(Y221F). We designed this mutant to function independently of
endogenous CrkII by endowing it with two properties: first, the
ability to bypass the phosphorylation-dependent recruitment to
the membrane (Abassi and Vuori, 2002), and second, resistance
to phosphorylation by replacement of tyrosine 221with phenylal-
anine. During inhibition, while endogenous CrkII would still be
inactivated through phosphorylation and dissociation from
c-Cbl, p130CAS, andC3G, the scaffold proteins andC3G should
be free to associate with the membrane-targeted CrkII. To
achieve membrane targeting of CrkII, we fused the 16 N-terminal
amino acids of the kinase Lyn to theN terminus of CrkII (Lyn-Crk).
YTS-2DL1 cells were stably transfected with wild-type CrkII
(Crk), CrkII-Y221F (Crk-YF), membrane-targeted CrkII (Lyn-
Crk), and membrane-targeted Lyn-CrkII-Y221F (Lyn-Crk-YF).
Stable clones expressing the different forms of CrkII were ob-
tained readily, except for Lyn-Crk-YF, for which the few clones
obtained expressed low amounts of Lyn-Crk-YF. YTS-2DL1 cells
expressing CrkII and each of the three CrkII mutants were tested
for their ability to receive inhibitory signals upon binding to HLA-
Cw4 on target cells. Inhibition comparable to that obtained with
YTS-2DL1 cells was observed with YTS-2DL1 cells expressing
Lyn-Crk (Figure 6). In contrast, inhibition of YTS-2DL1 cells
expressing membrane-targeted Lyn-Crk-YF was reduced (Fig-
ure 6). Several experiments were carried out with YTS-2DL1 cells
expressing Crk and each of the three Crkmutants (Figure 6B). In-
hibition was unimpaired in YTS-2DL1 cells expressing wild-type
Crk, Crk-YF, and Lyn-Crk. In contrast, reduced inhibition wasImmunity 29, 578–588, October 17, 2008 ª2008 Elsevier Inc. 583
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loss of inhibition was more pronounced in those experiments
in which inhibition of YTS-2DL1 cells was not complete
(Figure 6B). The reversal of inhibition caused by membrane tar-
geting of a nonphosphorylated CrkII implies that CrkII phosphor-
ylation contributes to inhibition of NK cell cytotoxicity.
DISCUSSION
Our study offers a new perspective on inhibitory signaling by
ITIM-containing receptors. Using MHC class I-specific inhibitory
receptors of NK cells as a model for ITIM signaling, we show that
Figure 6. Membrane Targeting of CrkII-Y221F Overcomes Inhibition
YTS-2DL1 cells, either untransfected () or transfected with wild-type CrkII
(Crk), CrkII-Y221F (Crk-YF), Lyn-tagged wild-type CrkII (Lyn-Crk), and Lyn-
tagged CrkII-Y221F (Lyn-Crk-YF), were tested for their ability to lyse 221-
Cw3 and 221-Cw4 cells.
(A) Lysis of 221-Cw3 cells (black bars) and 221-Cw4 cells (shaded bars) at an
effector-to-target ratio of 10.
(B) Inhibition of lysis, i.e., [(lysis of Cw3  lysis of Cw4)/(lysis of Cw3)] 3 100,
observed in multiple experiments. Similar results were obtained in experi-
ments with 221-Cw15 cells as resistant target cells. Each cluster of symbols
represents a separate experiment. Left panel: Inhibition of YTS-2DL1 cells
(triangles) is compared with inhibition of YTS-2DL1 cells transfected with Crk
(open circles) or Crk-YF (filled circles). Right panel: Inhibition of YTS-2DL1 cells
(triangles) is compared with inhibition of YTS-2DL1 cells transfected with
membrane-targeted Lyn-Crk (open circles) or membrane-targeted Lyn-Crk-
YF (filled circles).584 Immunity 29, 578–588, October 17, 2008 ª2008 Elsevier Inc.inhibition involves not only dephosphorylation of Vav1, but also
phosphorylation of a regulatory tyrosine in the adaptor Crk.
The fact that a specific tyrosine-phosphorylation event occurs
in NK cells during inhibition by MHC class I-positive target cells
begs a re-evaluation of the inhibitory mechanism and the signal-
ing potential of ITIM-containing receptors.
Signals transmitted by inhibitory KIR2DL1 and by CD94-
NKG2A were studied in the proper context of interactions be-
tween NK cells and target cells that express defined HLA ligands
of these two inhibitory receptors. Signals were analyzed bio-
chemically after engagement of activating and inhibitory recep-
tors of NK cells by their natural ligands on target cells in the
absence of Abs. Such an experimental approach entails techni-
cal challenges because signaling events occurring in a popula-
tion of cells engaged in synapse formation with other cells are
not synchronized and are weaker than after artificial crosslinking
of receptors with Abs. The only difference between activating
and inhibitory conditions in our experimental system was ex-
pression of HLA-C or HLA-E on target cells. Association of the
adaptor Crk with the scaffold protein c-Cbl and the Rap1 GEF
C3G, which were induced by contact of NK cells with sensitive
target cells, did not occur during inhibitory NK-target cell
contacts. Evenmore striking than the absence of specific signals
were the tyrosine phosphorylation of Crk and the association of
Crk with the tyrosine kinase c-Abl during inhibition only. There-
fore, it is clear that tyrosine dephosphorylation by SHP-1 is not
the only outcome of ITIM-mediated signaling and that ITIM-
containing receptors can also induce specific tyrosine phos-
phorylation.
The specific tyrosine phosphorylation of Crk and its associa-
tion with c-Abl were observed during inhibition by two unrelated
receptors, the type I transmembrane, Ig-like KIR2DL1, and the
type II transmembrane, lectin-like CD94-NKG2A. YTS cells ex-
pressing KIR2DL1 were tested with 221-Cw3 cells for activation
and 221-Cw15 cells for inhibition, whereas 221 and 221-E target
cells were used for a similar analysis of NKL cells, which express
CD94-NKG2A. Therefore, the formal possibility that some un-
known difference between 221-Cw3 and 221-Cw15 cells, be-
sides expression of these two different HLA-C allotypes, would
be responsible for changes in Crk phosphorylation in YTS-
2DL1 cells is extremely unlikely, given that similar results were
obtained with different target cells for the two NK cell lines. Crk
phosphorylation and formation of Crk-Abl complexes appear
to be a general feature of inhibition by different types of ITIM-
containing receptors. The new mechanism described here is
also relevant to inhibition of primary NK cells, in which formation
of Crk-c-Abl complexes was detected during inhibition.
Because c-Cbl-Crk complexes contribute to actin reorganiza-
tion and formation of lamellae (Abassi and Vuori, 2002; Bouton
et al., 2001; Scaife and Langdon, 2000), dissociation of Crk could
impair actin-dependent synapse formation between NK cells
and target cells. Crk enhances lamellipodiae formation by
recruiting C3G, a GEF for Rap1, or DOCK180, an activator of
Rac1, to its SH3 domain (Buensuceso and O’Toole, 2000). Tyro-
sine phosphorylation of c-Cbl and p130CAS and formation of
p130CAS-Crk complexes are induced by integrin signaling
(Chodniewicz and Klemke, 2004; Liu and Altman, 1998). The
role of GTPase Rap1 in promoting LFA-1-dependent adhesion
through ‘‘inside-out’’ signaling (Katagiri et al., 2003) and the
Immunity
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c-Cbl and p130CAS may result in negative regulation of LFA-1
signals. Binding of inhibitory KIR to HLA-C on target cells does
indeed inhibit LFA-1-mediated adhesion (Burshtyn et al., 2000).
A known mechanism for dissociation of Crk from c-Cbl and
p130CAS is the phosphorylation of Y221 in Crk by the kinase
c-Abl, rather than dephosphorylation of tyrosines in c-Cbl and
p130CAS (Abassi and Vuori, 2002; Holcomb et al., 2006; Shish-
ido et al., 2001). Crk phosphorylation by c-Abl involves a transient
Crk-c-Abl complex, in which Crk is autoinhibited by its own SH2
domain bound to pY221 (Abassi and Vuori, 2002; Shishido et al.,
2001). Consistent with the known functions of Crk and of Vav1,
inhibition by ITIM-containing receptors blocks actin-dependent
processes, such as actin cytoskeleton reorganization, phos-
phorylation of activation receptors NKG2D and 2B4 and their re-
cruitment to cholesterol-enriched membrane domains, and lipid
raft accumulation at the synapse (Dietrich et al., 2001; Endt et al.,
2007; Fassett et al., 2001; Guerra et al., 2002; Masilamani et al.,
2006; Watzl and Long, 2003). Therefore, inhibition of both Vav1
and Crk-mediated signals could serve to achieve more effective
inhibition.
Besides its role in actin cytoskeleton remodeling, c-Cbl also
serves as a negative regulator of immune responses through
its E3 ubiquitin ligase activity (Liu, 2004; Thien and Langdon,
2005). c-Cbl-dependent ubiquitination of molecules, such as
TCR z chain and Src-family kinases, targets these signaling com-
ponents for degradation by proteasomes. c-Cbl-mediated ubiq-
uitination also results in receptor internalization from the cell
surface (Balagopalan et al., 2007; Naramura et al., 2002). There-
fore, a contribution of c-Cbl to the inhibitory signal of KIR through
ubiquitination of signaling components had to be considered.
However, no ubiquitination of a number of proteins, including
known substrates for ubiquitination and proteins involved in
Figure 7. Two Components of Inhibitory
Signaling by ITIM-Containing Receptors
SHP-1 recruited by tyrosine-phosphorylated in-
hibitory receptor (KIR) dephosphorylates tyrosines
in Vav1 that regulate its GEF activity toward
Rac1. Red indicates inhibitory signaling. Green
indicates signaling for activation. Phosphorylated
Vav1-c-Cbl complexes, Crk-c-Cbl and Crk-C3G
complexes, form during activation. C3G has GEF
activity toward Rap1. During inhibition, Crk is not
associated with c-Cbl and C3G but is tyrosine
phosphorylated and bound to the tyrosine kinase
c-Abl. N indicates the N-terminal end of proteins.
Only the C-terminal region of c-Cbl is shown.
SH2 domain-phosphotyrosine (pY) interactions
are shown. Circles represent SH3 domains.
NK cell activation (c-Cbl, Vav1, CrkII,
CrkL, SHP-1, Grb-2, c-Abl, KIR2DL1,
Hck, and 2B4), could be detected in NK
cells mixed with either sensitive or resis-
tant target cells (data not shown).
There is general agreement that inhibi-
tion of NK cell cytotoxicity is achieved by
dephosphorylation of signaling compo-
nents at an early step in the activation
pathway (Billadeau and Leibson, 2002; Long, 2008; Long et al.,
2001). Activation signals that do not appear during inhibition ei-
ther are not occurring because of a block at an earlier signaling
step or are actively reversed by the inhibitory signaling pathway.
Substrate-trapping experiments that identified Vav1 as sub-
strate of SHP-1 in YTS cells (Stebbins et al., 2003) and in NK92
(this paper) imply that Vav1 is actively dephosphorylated during
inhibition. In this study, we provide evidence for another active
signaling process that occurs during inhibition and involves, sur-
prisingly, tyrosine phosphorylation of Crk, despite recruitment
and activation of the tyrosine phosphatase SHP-1. Inhibition
via ITIM-containing receptors can no longer be viewed simply
as a shutdown of tyrosine-phosphorylation events.
A functional experiment was designed to test whether Crk
phosphorylation and dissociation from c-Cbl contributed to inhi-
bition of NK cell cytotoxicity by KIR. The approach of choice was
for us to engineer a membrane-targeted and tyrosine-mutated
version of Crk (Lyn-Crk-YF) by fusion to the N-terminal sequence
of the kinase Lyn, in order to bypass the phosphorylation-depen-
dent Crk recruitment to the membrane. Despite very low expres-
sion of Lyn-Crk-YF in YTS-2DL1 cell clones, substantial lysis of
target cells was restored during incubation with 221-Cw15 cells,
which are normally protected through binding of KIR2DL1. Re-
versal of inhibition by expression of Lyn-Crk-YF was progres-
sively greater as overall inhibition of YTS-2DL1 by 221-Cw15
cells was reduced, suggesting that two inhibitory mechanisms,
such as Vav1 dephosphorylation and Crk phosphorylation, oper-
ate in parallel. It is worth noting that our experiment, in which cy-
totoxic function was restored, is a more stringent test of function
than experiments in which function is lost through inhibition or
loss of specific molecules.
Our results have revealed a second arm in the mechanism for
inhibition of NK cell cytotoxicity (Figure 7). One relies onImmunity 29, 578–588, October 17, 2008 ª2008 Elsevier Inc. 585
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tion of Crk from c-Cbl and C3G. A new question raised by these
findings is how ITIM-containing receptors orchestrate c-Abl re-
cruitment, Crk phosphorylation, and disassembly of c-Cbl-Crk-
C3G complexes. But regardless of the specific interactions in
this pathway, it is striking that engagement of inhibitory KIR by
HLA-C can result in a specific tyrosine-phosphorylation event.
The ability of an inhibitory KIR to promote tyrosine phosphor-
ylation widens the scope of potential functions for the many re-
ceptors in the ITIM family, such as the proposed ITIM-dependent
signal delivered by Ly49A to promote responsiveness of mouse
NK cells (Kim et al., 2005). Our biochemical data indeed suggest
that ITIM-dependent signaling could prevent NK cell unrespon-
siveness in the same manner that CD28 costimulation prevents
T cell anergy. A hallmark of anergic T cells is the presence of
constitutive c-Cbl-CrkL-C3G complexes and active Rap1 (Bous-
siotis et al., 1997). CD28 signaling suppresses TCR-dependent
activation of Rap1 (Reedquist and Bos, 1998). ITIM-dependent
inactivation of Rap1 by Crk phosphorylation may be used as
a similar mechanism to promote NK cell responsiveness.
EXPERIMENTAL PROCEDURES
Cell Lines and Reagents
721.221 cells (referred to as 221 in this paper) and 221 cells transfected with
HLA-Cw3, Cw4, Cw7, and Cw15 were obtained from J. Gumperz and P. Par-
ham (Stanford University). 221 cells transfected with an HLA-E carrying the
HLA-A2 signal peptide were obtained from D. Geraghty (Lee et al., 1998)
(Fred Hutchinson Cancer Research Center, Seattle, WA). 221 transfectants
were cultured in RPMI supplemented with glutamine, 10% fetal calf serum
(FCS), and 50 mM2-mercapto-ethanol. The humanNK cell line YTS transfected
with KIR2DL1 (YTS-2DL1, gift of G. Cohen, Massachusetts General Hospital,
Boston, MA) (Cohen et al., 1999) was cultured in Iscove’s (IMDM) supple-
mentedwith glutamine, 12.5%FCS, and 50 mM2-mercapto-ethanol. NKL cells
(Robertson et al., 1996), obtained fromM. Robertson (Indiana University Med-
ical Center), were cultured in RPMI supplemented with glutamine, 10% FCS,
50 mM 2-mercapto-ethanol, and 100 U/ml rIL-2. Human NK cells were isolated
from PBL with the MACS NK isolation kit (Miltenyi) and were grown in IMDM
supplemented with 10% human AB serum (Valley Biomedicals), 10% human
IL-2 (Hemagen), and 100 U/ml rIL-2 (Roche). KIR2DL1-positive NK cells
were isolated from bulk NK cell populations with KIR2DL1 antibody and anti-
mouse IgG Dynabeads (Dynal).
Antibodies
Antibodies were obtained from the following sources: Anti-KIR2DL1 (143211;
R&D Systems); Anti-Vav1 (3130; Abcam); Anti-phosphotyrosine (4G10; Up-
state); Anti-c-Cbl (A-9 and C-15), C3G (H-300), p130 CAS (N-20), c-myc
(9E10), c-Abl (K12), and Vav1 (H211) (Santa Cruz); Anti-pY160 Vav-1 (Bio-
source); Anti-c-Abl (8E9; BD Biosciences); Anti-c-Cbl (C9603; Sigma-Aldrich);
and Anti-pY221 CrkII (3491; Cell Signaling). Mouse PE-conjugated and rabbit
FITC-conjugated secondary antibodies for flow cytometry were from Jackson
Immunoresearch. Mouse, rabbit, and goat antibodies conjugated to horserad-
ish peroxidase (HRP) were from Santa Cruz. Streptavidin-HRP antibody was
from GE Healthcare.
DNA Mutagenesis and Transfections
Amyc-tagged rat CrkII cDNA (Cho and Klemke, 2000) (a gift of R. Klemke, Uni-
versity of California, San Diego) was subcloned into pCDNA3-hygro (Invitro-
gen) and subsequently mutagenizedwith Quick Change (Stratagene). Tyrosine
221 of CrkII was mutated to phenylalanine. An oligonucleotide encoding the 16
N-terminal amino acids of Lyn was inserted by ‘‘loop-in’’ mutagenesis, such
that this membrane-targeting sequence of Lyn was inserted in place of the ini-
tiationmethionine of CrkII and CrkII-Y221F. All final constructs were verified by
sequencing. YTS-2DL1 cells were transfected by electroporation and placed586 Immunity 29, 578–588, October 17, 2008 ª2008 Elsevier Inc.under 400 mg/ml Hygromycin B selection. Bulk populations were subcloned
and clones were screened for expression of CrkII by intracellular staining, im-
munoblotting, and RT-PCR.
Flow Cytometry
Cells were stained with directly conjugated antibodies or unlabeled antibodies
followed by fluorescently labeled secondary antibodies (diluted 1 to 200) in
phosphate-buffered saline (PBS) with 2.5% FCS and 0.1% NaN3. Samples
were analyzed on a BD Facscan with FlowJO software (Treestar).
Cytotoxicity Assays
For Europium-based cytotoxicity assays, target cells were labeled with 40 mM
BATDA (Perkin Elmer) for 30 min at 37C. Target cells were washed in medium
containing 1 mM Sulfinpyrazone (Sigma) and incubated with effector cells in
the presence of Sulfinpyrazone for 2 hr at 37C. Plates were mixed briefly
and centrifuged at 1200 rpm for 2 min. 20 ml of supernatant was incubated
with 200 ml of a 20% Europium solution (Perkin Elmer) in 0.3 M acetic acid
for 5 min and analyzed with a Wallac (Perkin Elmer) plate reader.
NK-Target Cell Mixing Experiments
5 3 106 YTS-2DL1 and 5 3 106 transfected 221 cells were incubated sepa-
rately on ice for 10 min. Cells were mixed and spun down, and media were
aspirated. The cell pellet was then incubated on ice for 10 min. Cells were
transferred to 37C for 5 min, moved to ice, and lysed in 1 ml of lysis buffer
(0.5% Triton X-100, 150 mM NaCl, 50 mM Tris-HCl [pH 7.4], 2 mM EGTA,
1 mM PMSF, and 1 mMNaVO3) for 20min. Nuclei were pelleted, and superna-
tants were incubated with 1 mg antibody plus protein G Sepharose beads (GE
Healthcare) for 1 hr. Beads were washed twice in lysis buffer and were resus-
pended in 20 ml of 1 3 NuPage LDS sample buffer (Invitrogen) containing
50 mM DTT. Beads were incubated at 70C for 10 min and then loaded on
either NuPage MOPS or TA (Invitrogen) gels. Proteins were transferred to
PVDF (Millipore) for 1 hr at 30 V in 1 3 NuPage transfer buffer (Invitrogen).
Membranes were blocked in PBSwith 0.5% Tween 20 and 5%BSA for at least
30 min and then incubated with primary antibody plus NaN3 for at least 1 hr.
Membranes were washed three times in PBS with 350 mM NaCl and 1%
Tween 20 for 5 min. Incubations with 1 3 104 dilutions of secondary anti-
bodies in a 1:1 mixture of blocking buffer and wash buffer were carried out
for 30 min. Blots were washed three times in PBS with 1% Tween 20 for
5 min and developed with either Super Signal West Dura or Pico (Pierce).
Membranes were exposed to Biomax MR film (Kodak) and developed. In
some cases, target cells were fixed before mixing. Cells were washed twice
in Hanks Balanced Salt Solution and incubated in 0.5% paraformaldehyde
for 5 min at room temperature. Cells were washed three times in complete me-
dium and then incubated at 37C for 1 hr. Cells were washed oncemore before
cell-mixing experiments.
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